MTOR and melanoma: Melanoma cells are characterized by a low sensitivity to apoptosis associated with high expression of antiapoptotic proteins of the BCL-2 family [7], loss of activity of Apaf-1 factor [54] and up-regulation of the PI3K/AKT/mTOR pathway [55].